Trials / Completed
CompletedNCT01283230
Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography
Prospective Cohort Study for Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography in Patients With Chronic Liver Disease and Healthy Liver/Kidney Donors
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective cohort Study for evaluation of liver fibrosis staging with acoustic radiation force impulse elastography in patients with chronic liver disease and healthy liver/kidney donors.
Detailed description
A recent new method for liver fibrosis assessment based on similar technology to transient elastography is acoustic radiation force impulse (ARFI) imaging. ARFI has the advantages which can be conducted in parallel ways of measuring points in the patients with chronic liver disease when they underwent routine ultrasound examination. Thus, the aim of this study was to identify the normal range of ARFI velocity and assess the best cut-off value by recruiting healthy living liver and kidney donors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Acoustic radiation force impulse imaging | Acoustic radiation force impulse (ARFI) imaging were measured 10 times in each patient.The region of interest was chosen in an area where the normal liver parenchyma was at least 6 cm thick and free of large blood vessels was chosen. A measurement depth of 2 cm below the liver capsule was chosen to standardize the examination. |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2011-01-25
- Last updated
- 2012-02-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01283230. Inclusion in this directory is not an endorsement.